Dirk Engels graduated as a medical doctor in 1979. He further holds diplomas in tropical medicine and hygiene, epidemiology, a Master's degree in health services research, and a PhD in parasitology. During the first 16 years of his professional career he successively worked in clinical tropical medicine, public health and tropical disease control, in Zambia, Zimbabwe, Burundi, Rwanda and Senegal, mostly serving people in poor rural settings. In 1998 he joined WHO where he was instrumental in developing norms and standards for the implementation of integrated large-scale preventive treatment interventions for the control or elimination of multiple tropical diseases. As Director of the Department of Control of Neglected Tropical Diseases, he steered the global expansion of interventions for the control and elimination of tropical diseases. Dr Engels retired from WHO in 2017.
Roderick James Hay is Chairman of the International Foundation for Dermatology and Professor of Cutaneous Infection and Consultant Dermatologist, Kings College London. He is emeritus Professor of Dermatology, Queens University Belfast (QUB) and honorary professor in the Clinical Research Unit, London School of Hygiene and Tropical Medicine. He was previously Head of the School of Medicine and Dentistry and Dean of the Faculty of Medicine and Health Sciences, QUB. Before this he was Dean and Clinical Director of the St John's Institute of Dermatology, London. He studied in Oxford University and Guys Hospital Medical School and after training in London and at the Centres for Disease Control, Atlanta; his first consultant post was in St John Hospital for Diseases of the Skin. He was appointed to the Mary Dunhill Chair of Cutaneous Medicine in London University in 1989. His academic and clinical interests are infectious skin disease, mycoses and tropical public health. He is former President of the British Association of Dermatologists and is a Fellow of the Academy of Medical Sciences.
Charles Mackenzie is a pathologist with expertise in tropical diseases. He has over 30 years experience of working closely with a number of countries in Africa and Latin America on onchocerciasis and lymphatic filariasis, as well as a long career at the London School of Hygiene and Tropical Medicine and Michigan State University researching the pathogenesis of filarial and other infectious diseases. His current work at the Task Force for Global Health involves the development of a laboratory support system to aid countries as they move to the elimination and control of NTDs, as well as catalyzing the global efforts to eliminate onchocerciasis. Charles is also the current Chair of the Global Alliance to Eliminate of Lymphatic Filariasis (GAELF), as well as other committees that focus on patient care for NTDs.
Toby Maurer is a dermatologist at the University of California San Fransisco. She is an expert in HIV dermatology and infectious diseases and an international lecturer and researcher in this field. Toby earned a medical degree at the University of Calgary in 1987. She completed residencies in family practice and dermatology and two fellowships in HIV medicine at UCSF. In her research, she is studying Kaposis sarcoma and teledermatology, which uses computer and video technology to diagnosis dermatologic conditions. She also has set up HIV dermatologic services and research in Uganda and Kenya. She is a professor at UCSF in Dermatology and chief of Dermatology at San Francisco General Hospital.
James McCarthy leads a multidisciplinary research team at the Queensland Institute of Medical Research undertaking research in human parasitology and translational research in tropical medicine. He holds a senior leadership position at QIMR, as Head of the Programme of Infectious Diseases, and serves as the QIMR representative in the Australian Infectious Diseases Research Centre. He is a Senior Consultant Physician in Infectious Diseases at the Royal Brisbane and Womens Hospital, and a Conjoint Professor of Medicine at The University of Queensland. His research areas include using experimental human malaria infection to improve the understanding of the pathogenesis of malaria and to develop new diagnostics, drugs and vaccines, improving the diagnosis and treatment of scabies and intestinal helminth infections and clinical trials of new drugs and vaccines for infectious diseases.